Cargando…

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

AIMS/HYPOTHESIS: Individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Eleuteri, Antonio, Fisher, Anthony C., Broadbent, Deborah M., García-Fiñana, Marta, Cheyne, Christopher P., Wang, Amu, Stratton, Irene M., Gabbay, Mark, Seddon, Daniel, Harding, Simon P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448900/
https://www.ncbi.nlm.nih.gov/pubmed/28840258
http://dx.doi.org/10.1007/s00125-017-4386-0
_version_ 1783408747719163904
author Eleuteri, Antonio
Fisher, Anthony C.
Broadbent, Deborah M.
García-Fiñana, Marta
Cheyne, Christopher P.
Wang, Amu
Stratton, Irene M.
Gabbay, Mark
Seddon, Daniel
Harding, Simon P.
author_facet Eleuteri, Antonio
Fisher, Anthony C.
Broadbent, Deborah M.
García-Fiñana, Marta
Cheyne, Christopher P.
Wang, Amu
Stratton, Irene M.
Gabbay, Mark
Seddon, Daniel
Harding, Simon P.
author_sort Eleuteri, Antonio
collection PubMed
description AIMS/HYPOTHESIS: Individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics, and explored differences in assignment compared with current practice. METHODS: Data from 5 years of photographic screening and primary care for people with diabetes, screen negative at the first of > 1 episode, were combined in a purpose-built near-real-time warehouse. Covariates were selected from a dataset created using mixed qualitative/quantitative methods. Markov modelling predicted progression to screen-positive (referable diabetic retinopathy) against the local cohort history. Retinopathy grade informed baseline risk and multiple imputation dealt with missing data. Acceptable intervals (6, 12, 24 months) and risk threshold (2.5%) were established with patients and professional end users. RESULTS: Data were from 11,806 people with diabetes (46,525 episodes, 388 screen-positive). Covariates with sufficient predictive value were: duration of known disease, HbA(1c), age, systolic BP and total cholesterol. Corrected AUC (95% CIs) were: 6 months 0.88 (0.83, 0.93), 12 months 0.90 (0.87, 0.93) and 24 months 0.91 (0.87, 0.94). Sensitivities/specificities for a 2.5% risk were: 6 months 0.61, 0.93, 12 months 0.67, 0.90 and 24 months 0.82, 0.81. Implementing individualised RCE-based intervals would reduce the proportion of people becoming screen-positive before the allocated screening date by > 50% and the number of episodes by 30%. CONCLUSIONS/INTERPRETATION: The Liverpool RCE shows sufficient performance for a local introduction into practice before wider implementation, subject to external validation. This approach offers potential enhancements of screening in improved local applicability, targeting and cost-effectiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-017-4386-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6448900
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64489002019-04-17 Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine Eleuteri, Antonio Fisher, Anthony C. Broadbent, Deborah M. García-Fiñana, Marta Cheyne, Christopher P. Wang, Amu Stratton, Irene M. Gabbay, Mark Seddon, Daniel Harding, Simon P. Diabetologia Article AIMS/HYPOTHESIS: Individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics, and explored differences in assignment compared with current practice. METHODS: Data from 5 years of photographic screening and primary care for people with diabetes, screen negative at the first of > 1 episode, were combined in a purpose-built near-real-time warehouse. Covariates were selected from a dataset created using mixed qualitative/quantitative methods. Markov modelling predicted progression to screen-positive (referable diabetic retinopathy) against the local cohort history. Retinopathy grade informed baseline risk and multiple imputation dealt with missing data. Acceptable intervals (6, 12, 24 months) and risk threshold (2.5%) were established with patients and professional end users. RESULTS: Data were from 11,806 people with diabetes (46,525 episodes, 388 screen-positive). Covariates with sufficient predictive value were: duration of known disease, HbA(1c), age, systolic BP and total cholesterol. Corrected AUC (95% CIs) were: 6 months 0.88 (0.83, 0.93), 12 months 0.90 (0.87, 0.93) and 24 months 0.91 (0.87, 0.94). Sensitivities/specificities for a 2.5% risk were: 6 months 0.61, 0.93, 12 months 0.67, 0.90 and 24 months 0.82, 0.81. Implementing individualised RCE-based intervals would reduce the proportion of people becoming screen-positive before the allocated screening date by > 50% and the number of episodes by 30%. CONCLUSIONS/INTERPRETATION: The Liverpool RCE shows sufficient performance for a local introduction into practice before wider implementation, subject to external validation. This approach offers potential enhancements of screening in improved local applicability, targeting and cost-effectiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-017-4386-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2017-08-24 2017 /pmc/articles/PMC6448900/ /pubmed/28840258 http://dx.doi.org/10.1007/s00125-017-4386-0 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Eleuteri, Antonio
Fisher, Anthony C.
Broadbent, Deborah M.
García-Fiñana, Marta
Cheyne, Christopher P.
Wang, Amu
Stratton, Irene M.
Gabbay, Mark
Seddon, Daniel
Harding, Simon P.
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
title Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
title_full Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
title_fullStr Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
title_full_unstemmed Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
title_short Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
title_sort individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the liverpool risk calculation engine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448900/
https://www.ncbi.nlm.nih.gov/pubmed/28840258
http://dx.doi.org/10.1007/s00125-017-4386-0
work_keys_str_mv AT eleuteriantonio individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT fisheranthonyc individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT broadbentdeborahm individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT garciafinanamarta individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT cheynechristopherp individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT wangamu individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT strattonirenem individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT gabbaymark individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT seddondaniel individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT hardingsimonp individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine
AT individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine